Cite
Meng DF, Sun R, Peng LX, et al. A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study. J Cancer. 2018;9(1):92-99doi: 10.7150/jca.21357.
Meng, D. F., Sun, R., Peng, L. X., Huang, Y. S., Yang, Q., Luo, D. H., Hu, W. H., Xie, F. Y., Luo, W., Zhao, C., Guo, L., Mai, H. Q., Chen, M. Y., Xie, P., Zheng, L. S., Yang, J. P., Mei, Y., Qiang, Y. Y., Xu, L., Li, C. Z., Huang, B. J., Qian, C. N., & Sun, R. (2018). A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study. Journal of Cancer, 9(1), 92-99. https://doi.org/10.7150/jca.21357
Meng, Dong-Fang, et al. "A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study." Journal of Cancer vol. 9,1 (2018): 92-99. doi: https://doi.org/10.7150/jca.21357
Meng DF, Sun R, Peng LX, Huang YS, Yang Q, Luo DH, Hu WH, Xie FY, Luo W, Zhao C, Guo L, Mai HQ, Chen MY, Xie P, Zheng LS, Yang JP, Mei Y, Qiang YY, Xu L, Li CZ, Huang BJ, Qian CN, Sun R. A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study. J Cancer. 2018 Jan 01;9(1):92-99. doi: 10.7150/jca.21357. eCollection 2018. PMID: 29290773; PMCID: PMC5743715.
Copy
Download .nbib